Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Moriondo

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Clinical Endocrinology|December 1, 1980
Evaluation of two inhibitory tests (nomifensine and L-dopa + carbidopa) for the diagnosis of hyperprolactinaemic statesP Moriondo, P Travaglini, M Nissim, et al.
JAMA|December 12, 1980
Prolactin and sexual functionB Ambrosi, M Gaggini, P Moriondo, et al.
Lancet (London, England)|January 15, 1983
Influence of previous bromocriptine therapy on surgery for microprolactinomaG Faglia, P Moriondo, P Travaglini, et al.
The Journal of Clinical Endocrinology and Metabolism|April 1, 1985
Bromocriptine treatment of microprolactinomas: evidence of stable prolactin decrease after drug withdrawalP Moriondo, P Travaglini, M Nissim, et al.
Journal of Endocrinological Investigation|October 1, 1979
Serum LH increase after estradiol and progesterone administration in hyperprolactinemic womenP Travaglini, R Elli, B Ambrosi, et al.
Journal of Endocrinological Investigation|July 1, 1981
Hypothalamic-pituitary-testicular function in men with PRL-secreting tumorsB Ambrosi, M Gaggini, P Travaglini, et al.
Journal of Clinical & Laboratory Immunology|June 1, 1986
Increase of OKT4+ cells during treatment with thymostimulin in parenteral drug addicts with persistent generalized lymphadenopathyA Lazzarin, M Galli, P Moriondo, et al.
Acta Endocrinologica|May 1, 1982
Effect of bromocriptine and metergoline in the treatment of hyperprolactinaemic statesB Ambrosi, P Travaglini, P Moriondo, et al.
Andrologia|January 1, 1979
Effects of serotonin antagonists in sexually impotent menB Ambrosi, P Travaglini, M Gaggini, et al.
Neuroendocrinology|January 1, 1979
Restoration of the prolactin response to sulpiride by metergoline administration in hyperprolactinemic patientsC Ferrari, P Travaglini, R Caldara, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Clinical Endocrinology|December 1, 1980
Evaluation of two inhibitory tests (nomifensine and L-dopa + carbidopa) for the diagnosis of hyperprolactinaemic statesP Moriondo, P Travaglini, M Nissim, et al.
JAMA|December 12, 1980
Prolactin and sexual functionB Ambrosi, M Gaggini, P Moriondo, et al.
Lancet (London, England)|January 15, 1983
Influence of previous bromocriptine therapy on surgery for microprolactinomaG Faglia, P Moriondo, P Travaglini, et al.
The Journal of Clinical Endocrinology and Metabolism|April 1, 1985
Bromocriptine treatment of microprolactinomas: evidence of stable prolactin decrease after drug withdrawalP Moriondo, P Travaglini, M Nissim, et al.
Journal of Endocrinological Investigation|October 1, 1979
Serum LH increase after estradiol and progesterone administration in hyperprolactinemic womenP Travaglini, R Elli, B Ambrosi, et al.
Journal of Endocrinological Investigation|July 1, 1981
Hypothalamic-pituitary-testicular function in men with PRL-secreting tumorsB Ambrosi, M Gaggini, P Travaglini, et al.
Journal of Clinical & Laboratory Immunology|June 1, 1986
Increase of OKT4+ cells during treatment with thymostimulin in parenteral drug addicts with persistent generalized lymphadenopathyA Lazzarin, M Galli, P Moriondo, et al.
Acta Endocrinologica|May 1, 1982
Effect of bromocriptine and metergoline in the treatment of hyperprolactinaemic statesB Ambrosi, P Travaglini, P Moriondo, et al.
Andrologia|January 1, 1979
Effects of serotonin antagonists in sexually impotent menB Ambrosi, P Travaglini, M Gaggini, et al.
Neuroendocrinology|January 1, 1979
Restoration of the prolactin response to sulpiride by metergoline administration in hyperprolactinemic patientsC Ferrari, P Travaglini, R Caldara, et al.
Pageof 2